You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

TRIENTINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Trientine Hydrochloride, and what generic alternatives are available?

Trientine Hydrochloride is a drug marketed by Accord Hlthcare, Amneal, Chartwell Rx, Dr Reddys, Eci Pharms Llc, Endo Operations, Hetero Labs Ltd Iii, Lupin Ltd, MSN, Navinta Llc, Rising, Watson Labs Teva, and Zydus Pharms. and is included in thirteen NDAs.

The generic ingredient in TRIENTINE HYDROCHLORIDE is trientine hydrochloride. There are ten drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the trientine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Trientine Hydrochloride

A generic version of TRIENTINE HYDROCHLORIDE was approved as trientine hydrochloride by WATSON LABS TEVA on February 7th, 2018.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TRIENTINE HYDROCHLORIDE?
  • What are the global sales for TRIENTINE HYDROCHLORIDE?
  • What is Average Wholesale Price for TRIENTINE HYDROCHLORIDE?
Summary for TRIENTINE HYDROCHLORIDE
US Patents:0
Applicants:13
NDAs:13
Finished Product Suppliers / Packagers: 11
Raw Ingredient (Bulk) Api Vendors: 73
Clinical Trials: 13
Patent Applications: 211
What excipients (inactive ingredients) are in TRIENTINE HYDROCHLORIDE?TRIENTINE HYDROCHLORIDE excipients list
DailyMed Link:TRIENTINE HYDROCHLORIDE at DailyMed
Drug patent expirations by year for TRIENTINE HYDROCHLORIDE
Recent Clinical Trials for TRIENTINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
OrphalanPhase 1
Alexion PharmaceuticalsPhase 2
University of OxfordPhase 2

See all TRIENTINE HYDROCHLORIDE clinical trials

Pharmacology for TRIENTINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for TRIENTINE HYDROCHLORIDE

US Patents and Regulatory Information for TRIENTINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare TRIENTINE HYDROCHLORIDE trientine hydrochloride CAPSULE;ORAL 212929-001 Aug 30, 2021 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hetero Labs Ltd Iii TRIENTINE HYDROCHLORIDE trientine hydrochloride CAPSULE;ORAL 216356-001 Jun 23, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Dr Reddys TRIENTINE HYDROCHLORIDE trientine hydrochloride CAPSULE;ORAL 211076-001 Jul 3, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rising TRIENTINE HYDROCHLORIDE trientine hydrochloride CAPSULE;ORAL 212238-002 Sep 22, 2023 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.